Why switch from protease inhibitors (PI) to non-nucleoside reverse transcriptase inhibitors (NNRTI)?

HIV Med. 2000:1 Suppl 1:7-10. doi: 10.1046/j.1468-1293.2000.00006.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • Drug Therapy, Combination
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / drug effects
  • HIV-1 / physiology
  • Humans
  • Protease Inhibitors / adverse effects
  • Protease Inhibitors / therapeutic use*
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • Protease Inhibitors
  • Reverse Transcriptase Inhibitors